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Prediabetes Shared Decision-Making for Primary Care Patients
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BACKGROUND
•  38% of adults in the United States have prediabetes.1 
•  Once diagnosed with prediabetes, the annual risk of developing diabetes is 5–10%, 
with a 74% lifetime risk if diagnosed prior to age 45.2,3
•  Many patients do not know that they have prediabetes, and those who have been 
diagnosed are often not offered treatment options to prevent or delay diabetes.
•  Given escalating rates of prediabetes, tools for brief office-based interventions are 
needed to mitigate rates of progression to diabetes and its associated complications.
METHODS
•  A Patient and Stakeholder Advisory Committee (PASAC) consisting of patients, 
clinicians, clinical educators, a pharmacist, and endocrinologist co-created a 
prediabetes shared decision-making (SDM) tool (infographic/decision aid).
•  Surveys administered to patients/clinicians after pilot to assess impact on decision 
making and feasibility of intervention.
RESULTS
POST-INTERVENTION PATIENT SURVEY DATA
TABLE 1
Initial Post-Encounter Patient Survey (n=50) Strongly Agree Agree Neutral Disagree
Strongly 
Disagree
My doctor and I made a decision together about how  
to treat my prediabetes during my visit 60% 32% 6% - 2% 
I had an important role in the decision-making process 66% 28% 6% - -
The shared decision-making tool prepared me to make 
a decision about my prediabetes prevention plan 48% 48% 4% - -
The shared decision-making tool helped me think 
about the pros and cons of each option to prevent 
diabetes
56% 44% - - -
The shared decision-making tool helped me think 
about which pros and cons are most important to  
me (n=49)
56% 42% - - -
TABLE 2
Second 6-week Post-Encounter Patient Survey 
(n=25)
Strongly 
Agree Agree Neutral Disagree
Strongly 
Disagree
I have been following the diabetes prevention plan  
most days 15.4% 65.4% 11.5% - 3.8%
My plan reflects what my doctor and I discussed 23.1% 61.5% 7.7% - 3.8%
I am considering changing my diabetes  
prevention plan 7.7% 19.2% 19.2% 34.6% 15.4%
POST-INTERVENTION CLINICIAN SURVEY DATA
•  100% of clinicians (n=5) would use the SDM tool again with 
patients who have prediabetes
•  100% of clinicians stated there was no change in the visit length 
due to using the tool
TABLE 3
Clinician Survey (n=2)) Strongly Agree Agree
The prediabetes tool helped me to provide more information to my  
patients than I have in the past 50% 50%
The SDM tool helped me to explain prediabetes to my patients 50% 50%
The SDM tool made it easier to include patients in the decision- 
making process 50% 50%
The SDM tool made it easier to understand what values were most 
important to my patients 50% 50%
DISCUSSION
Use of a PASAC allowed voices of patients and health system members to 
inform development of a prediabetes infographic/decision aid tool. 
Study modified in response to PASAC feedback to pilot intervention in non-
Hispanic as well as Hispanic patients with prediabetes.
Patients and clinicians involved in the pilot intervention reported a conversation 
about diabetes prevention that may not have otherwise occurred. 
The prediabetes tool was found to be feasible in terms of reported impact on 
visit length.
FUTURE DIRECTIONS
Modifications will be made to the prediabetes tool based on patient, clinician, 
and PASAC feedback.
A comparative effectiveness study will determine the most effective strategy to 
facilitate diabetes prevention discussions in the primary care setting.
Further study will be done to determine intervention impact on patient and 
clinician behavior change and patient biomarkers (BMI, HbA1c).
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•  Discussion of results and implications
•  Revision of infographic/decision aid
•  Plan for next steps
Figure 1: Pre-PASAC Infographic 
to Accompany Decision Aid




 Hispanic Ethnicity 
 History of Gesta�onal Diabetes 
 Being Overweight 
 Family  History  
 Excessive thirst and urina�on 
 Numbness in hands and feet 




Blood Sugar   
can be  
controlled with  
medica�on  
such as Me�ormin 
What is Prediabetes? 
 Your sugar is higher than it should 
be (fas�ng glucose between 100‐
125 and/or HbA1c between 5.7‐
6.4) 







Loss of Toes, 
Feet, or Legs 
Kidney Failure Blindness Stroke Heart Disease 
Progression to Diabetes Can be Reversed 
